McKesson Management

Management criteria checks 3/4

McKesson's CEO is Brian Tyler, appointed in Apr 2019, has a tenure of 5.42 years. total yearly compensation is $19.00M, comprised of 7.8% salary and 92.2% bonuses, including company stock and options. directly owns 0.061% of the company’s shares, worth $37.76M. The average tenure of the management team and the board of directors is 3.4 years and 3 years respectively.

Key information

Brian Tyler

Chief executive officer

US$19.0m

Total compensation

CEO salary percentage7.8%
CEO tenure5.4yrs
CEO ownership0.06%
Management average tenure3.4yrs
Board average tenure3yrs

Recent management updates

Recent updates

McKesson: The Correction Is Not Over

Sep 10

McKesson Corporation (NYSE:MCK) Not Lagging Market On Growth Or Pricing

Aug 22
McKesson Corporation (NYSE:MCK) Not Lagging Market On Growth Or Pricing

McKesson Corporation: An Interesting Health Giant With A Hidden Gem

Jul 04

With McKesson Corporation (NYSE:MCK) It Looks Like You'll Get What You Pay For

May 09
With McKesson Corporation (NYSE:MCK) It Looks Like You'll Get What You Pay For

Is McKesson Corporation (NYSE:MCK) Trading At A 43% Discount?

Mar 14
Is McKesson Corporation (NYSE:MCK) Trading At A 43% Discount?

McKesson: GLP-1 Contributed More Than 1/3 Of Growth

Feb 19

McKesson's (NYSE:MCK) Profits May Not Reveal Underlying Issues

Feb 16
McKesson's (NYSE:MCK) Profits May Not Reveal Underlying Issues

Investor Optimism Abounds McKesson Corporation (NYSE:MCK) But Growth Is Lacking

Jan 29
Investor Optimism Abounds McKesson Corporation (NYSE:MCK) But Growth Is Lacking

McKesson: Why The Company Is Too Richly Valued

Jan 19

If EPS Growth Is Important To You, McKesson (NYSE:MCK) Presents An Opportunity

Nov 20
If EPS Growth Is Important To You, McKesson (NYSE:MCK) Presents An Opportunity

McKesson: GLP-1 Medications Tailwinds And Massive Share Repurchase

Nov 08

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 44%?

Oct 30
Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 44%?

McKesson: Still Trading For A Huge Discount

Sep 06

Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

Aug 21
Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 29%?

Jul 27
Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 29%?

McKesson: Outlook Remains Positive, I Reiterate My Buy Recommendation

Jun 28

Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

May 23
Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 32%?

Apr 17
Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 32%?

Do McKesson's (NYSE:MCK) Earnings Warrant Your Attention?

Feb 22
Do McKesson's (NYSE:MCK) Earnings Warrant Your Attention?

McKesson Corporation: Looking Forward To Long-Term Low-Teens EPS Growth

Feb 08

McKesson Non-GAAP EPS of $6.90 beats by $0.54, revenue of $70.5B misses by $480M

Feb 01

McKesson Corporation's (NYSE:MCK) Intrinsic Value Is Potentially 33% Above Its Share Price

Jan 12
McKesson Corporation's (NYSE:MCK) Intrinsic Value Is Potentially 33% Above Its Share Price

5 Reasons Why I Am Considering Adding McKesson To My Portfolio

Dec 27

McKesson Corporation: Still Trading Below Intrinsic Value

Dec 13

Duration: The Time Bomb In Your Portfolio - McKesson And PayPal In Focus

Oct 08

McKesson extends distribution partnership with CVS Health

Sep 29

An Intrinsic Calculation For McKesson Corporation (NYSE:MCK) Suggests It's 50% Undervalued

Sep 19
An Intrinsic Calculation For McKesson Corporation (NYSE:MCK) Suggests It's 50% Undervalued

McKesson to acquire Rx Savings Solutions in $875M deal

Sep 19

CEO Compensation Analysis

How has Brian Tyler's remuneration changed compared to McKesson's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

US$3b

Mar 31 2024US$19mUS$1m

US$3b

Dec 31 2023n/an/a

US$3b

Sep 30 2023n/an/a

US$3b

Jun 30 2023n/an/a

US$4b

Mar 31 2023US$20mUS$1m

US$4b

Dec 31 2022n/an/a

US$3b

Sep 30 2022n/an/a

US$2b

Jun 30 2022n/an/a

US$1b

Mar 31 2022US$18mUS$1m

US$1b

Dec 31 2021n/an/a

US$1b

Sep 30 2021n/an/a

-US$5b

Jun 30 2021n/an/a

-US$4b

Mar 31 2021US$15mUS$1m

-US$5b

Dec 31 2020n/an/a

-US$4b

Sep 30 2020n/an/a

US$2b

Jun 30 2020n/an/a

US$922m

Mar 31 2020US$15mUS$1m

US$906m

Dec 31 2019n/an/a

-US$905m

Sep 30 2019n/an/a

-US$626m

Jun 30 2019n/an/a

US$601m

Mar 31 2019US$13mUS$929k

US$33m

Compensation vs Market: Brian's total compensation ($USD19.00M) is above average for companies of similar size in the US market ($USD13.03M).

Compensation vs Earnings: Brian's compensation has been consistent with company performance over the past year.


CEO

Brian Tyler (57 yo)

5.4yrs

Tenure

US$18,997,543

Compensation

Mr. Brian S. Tyler, Ph D., has been an Independent Director at Republic Services, Inc. since April 1, 2021. He served as Chairman of Supervisory Board at McKesson Europe AG since August 9, 2018 until 2022....


Leadership Team

NamePositionTenureCompensationOwnership
Brian Tyler
CEO & Director5.4yrsUS$19.00m0.061%
$ 37.8m
Britt Vitalone
Executive VP & CFO6.7yrsUS$6.78m0.011%
$ 7.0m
Michele Lau
Executive VP & Chief Legal Officerless than a yearUS$8.81m0.00011%
$ 68.3k
LeAnn Smith
Executive VP & Chief Human Resources Officer1.8yrsUS$3.54m0.0016%
$ 969.3k
Thomas Rodgers
Executive VP and Chief Strategy & Business Development Officer4.3yrsUS$3.18m0.0020%
$ 1.2m
Napoleon Rutledge
Senior VP2.5yrsno data0.0015%
$ 944.4k
Francisco Fraga
Executive VPless than a yearno datano data
Rachel Rodriguez
Vice President of Investor Relationsno datano datano data
Pete Slone
Senior Vice President of Corporate Public Affairs9.3yrsno datano data
Kirk Kaminsky
President of The US Pharmaceutical & Specialty Solutions Business5.4yrsno datano data
Paul Smith
Senior Vice President of Taxesno datano datano data
Kevin Emerson
Senior Vice President of Finance Operations2.5yrsno datano data

3.4yrs

Average Tenure

51.5yo

Average Age

Experienced Management: MCK's management team is considered experienced (3.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Brian Tyler
CEO & Director5.4yrsUS$19.00m0.061%
$ 37.8m
Donald Knauss
Independent Chairman of the Board9.9yrsUS$555.22k0.0016%
$ 994.1k
Maria Martinez
Independent Director4.9yrsUS$335.08k0.00027%
$ 167.8k
Dominic Caruso
Independent Director6yrsUS$336.21k0.00027%
$ 167.8k
Deborah Dunsire
Directorless than a yearno datano data
James Hinton
Independent Director2.7yrsUS$315.08k0%
$ 0
Webster Dunbar
Independent Director2.4yrsUS$315.08k0%
$ 0
Kathleen Wilson-Thompson
Independent Director2.7yrsUS$315.08k0%
$ 0
Richard Carmona
Independent Director3yrsUS$313.71k0%
$ 0
Kevin Ozan
Independent Directorless than a yearUS$139.34k0.000010%
$ 6.2k
Bradley Lerman
Independent Director6.4yrsUS$328.71k0%
$ 0

3.0yrs

Average Tenure

66yo

Average Age

Experienced Board: MCK's board of directors are considered experienced (3 years average tenure).